Related Experiment Video

Updated: Jun 12, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.1K

Dual Kv7.2/3-TRPV1 modulators inhibit nociceptor hyperexcitability and alleviate pain without target-related side

Adi Raveh1, Yefim Pen1, Alon Silberman1

  • 1Bsense Bio Therapeutics Ltd., Ness Ziona, Israel.

Pain
|September 26, 2024
PubMed

Insights

New dual-action compounds simultaneously activate Kv7.2/3 channels and inhibit TRPV1 channels, offering a novel therapeutic approach for chronic pain. This dual modulation shows significant pain relief in animal models without common side effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Chronic pain affects millions, with current treatments often limited by efficacy or side effects.
  • Nociceptor hyperexcitability, involving TRPV1 and Kv7.2/3 channels, is central to pain mechanisms.
  • Previous drug development targeting TRPV1 or Kv7.2/3 individually faced challenges with side effect profiles.

Purpose of the Study:

  • To identify and characterize novel small molecule analogues with a dual mechanism of action.
  • To investigate the simultaneous modulation of Kv7.2/3 and TRPV1 channels.
  • To evaluate the therapeutic potential of this dual modulation for chronic pain treatment.

Main Methods:

  • Pharmacological profiling of three novel small molecule analogues.
  • In vitro assays to assess Kv7.2/3 activation and TRPV1 inhibition.
  • In vivo studies in animal models of acute and chronic pain to evaluate analgesic efficacy.

Main Results:

  • The analogues demonstrated simultaneous activation of Kv7.2/3 and potent inhibition of TRPV1.
  • Compounds achieved significant analgesia in vivo across multiple pain models.
  • The novel mechanism of action was not associated with known class-specific side effects.

Conclusions:

  • Dual modulation of Kv7.2/3 and TRPV1 represents a promising therapeutic strategy for chronic pain.
  • Selective targeting of specific nociceptor subpopulations may explain the favorable efficacy and safety profile.
  • These compounds warrant further preclinical and clinical development for chronic pain management.

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 109:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.5K
Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

8.1K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
469
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
584
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
153
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
246